Zenas BioPharma Grants 100,000 Options at $18.71 and 78,075 RSUs
ZBIO•Zenas BioPharma granted new employees inducement awards on June 15, 2026, comprising 100,000 stock options at $18.71 exercise price and 78,075 restricted stock units under Nasdaq Rule 5635(c)(4). The options carry a ten-year term vesting over four years, while RSUs vest in four equal annual installments through June 15, 2030.
1. Inducement Grant Overview
On June 15, 2026, Zenas BioPharma’s Compensation Committee approved inducement grants for newly hired employees, awarding 100,000 non-qualified stock options and 78,075 restricted stock units under Nasdaq Listing Rule 5635(c)(4). These grants were made as material inducements for new hires and are governed by the company’s 2026 Inducement Plan.
2. Stock Option Terms
The 100,000 stock options carry a ten-year term with an exercise price of $18.71, equal to the closing share price on the grant date. Vesting occurs over a four-year period, with 25% of the options vesting on the one-year anniversary of each employee’s start date, followed by 36 equal monthly installments for the remaining 75%.
3. RSU Vesting Schedule
The 78,075 restricted stock units vest in four equal annual installments, with 25% of the RSUs vesting on each of June 15, 2027; June 15, 2028; June 15, 2029; and June 15, 2030. All RSU vesting is contingent on continuous employment through each respective vesting date.
4. Continued Service Conditions
Both the stock options and RSUs are subject to the recipients’ continued service with Zenas BioPharma through their respective vesting dates. All awards are subject to the terms and conditions of the 2026 Inducement Plan and the applicable award agreements.
